International Journal of Clinical Pharmacy

, Volume 37, Issue 6, pp 982–983 | Cite as

A critical appraisal of statistical pitfalls and clinical relevance of meta-analysis involving hepatitis C virus and sofosbuvir

  • Lucas Miyake OkumuraEmail author
Letter to the Editor


Critical Thinking Comparable Intervention Indirect Comparison Included Trial Sofosbuvir 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflicts of interest

The author does not have any conflicts of interest.


  1. 1.
    Yang HJ, Ryoo JY, Yoo BK. Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection. Int J Clin Pharm. 2015. doi: 10.1007/s11096-015-0144-x.
  2. 2.
    Lee AW. Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009. J Clin Epidemiol. 2014;67(2):138–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4. (numbers: NCT01641640, NCT01497366, NCT01542788, NCT01604850, NCT01682720, NCT01701401, NCT01768286, NCT01851330). Accessed 24 Jul 2015.
  5. 5.
    Higgins JPT, Green S (editors). Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. Cochrane Collab. 2011. Accessed 24 Jul 2015.

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  1. 1.Clinical Pharmacy DivisionHospital de Clínicas de Porto AlegrePorto AlegreBrazil

Personalised recommendations